These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10565819)

  • 21. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier.
    Liu L; Guo K; Lu J; Venkatraman SS; Luo D; Ng KC; Ling EA; Moochhala S; Yang YY
    Biomaterials; 2008 Apr; 29(10):1509-17. PubMed ID: 18155137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.
    Zensi A; Begley D; Pontikis C; Legros C; Mihoreanu L; Wagner S; Büchel C; von Briesen H; Kreuter J
    J Control Release; 2009 Jul; 137(1):78-86. PubMed ID: 19285109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability.
    Stamatovic SM; Shakui P; Keep RF; Moore BB; Kunkel SL; Van Rooijen N; Andjelkovic AV
    J Cereb Blood Flow Metab; 2005 May; 25(5):593-606. PubMed ID: 15689955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The MAP kinase pathway mediates transcytosis induced by TNF-alpha in an in vitro blood-brain barrier model.
    Miller F; Fenart L; Landry V; Coisne C; Cecchelli R; Dehouck MP; Buée-Scherrer V
    Eur J Neurosci; 2005 Aug; 22(4):835-44. PubMed ID: 16115207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of blood-brain barrier properties in cultured brain capillary endothelial cells: comparison between primary glial cells and C6 cell line.
    Boveri M; Berezowski V; Price A; Slupek S; Lenfant AM; Benaud C; Hartung T; Cecchelli R; Prieto P; Dehouck MP
    Glia; 2005 Aug; 51(3):187-98. PubMed ID: 15800928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier.
    Qiao R; Jia Q; Hüwel S; Xia R; Liu T; Gao F; Galla HJ; Gao M
    ACS Nano; 2012 Apr; 6(4):3304-10. PubMed ID: 22443607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro models for the blood-brain barrier.
    Garberg P; Ball M; Borg N; Cecchelli R; Fenart L; Hurst RD; Lindmark T; Mabondzo A; Nilsson JE; Raub TJ; Stanimirovic D; Terasaki T; Oberg JO; Osterberg T
    Toxicol In Vitro; 2005 Apr; 19(3):299-334. PubMed ID: 15713540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro.
    Kraus J; Ling AK; Hamm S; Voigt K; Oschmann P; Engelhardt B
    Ann Neurol; 2004 Aug; 56(2):192-205. PubMed ID: 15293271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiological pathway for low-density lipoproteins across the blood-brain barrier: transcytosis through brain capillary endothelial cells in vitro.
    Candela P; Gosselet F; Miller F; Buee-Scherrer V; Torpier G; Cecchelli R; Fenart L
    Endothelium; 2008; 15(5-6):254-64. PubMed ID: 19065317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury.
    Dimitrijevic OB; Stamatovic SM; Keep RF; Andjelkovic AV
    J Cereb Blood Flow Metab; 2006 Jun; 26(6):797-810. PubMed ID: 16192992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electromagnetic fields (GSM 1800) do not alter blood-brain barrier permeability to sucrose in models in vitro with high barrier tightness.
    Franke H; Ringelstein EB; Stögbauer F
    Bioelectromagnetics; 2005 Oct; 26(7):529-35. PubMed ID: 16142784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluvastatin stabilizes the blood-brain barrier in vitro by nitric oxide-dependent dephosphorylation of myosin light chains.
    Kuhlmann CR; Lessmann V; Luhmann HJ
    Neuropharmacology; 2006 Sep; 51(4):907-13. PubMed ID: 16872642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity.
    Rempe R; Cramer S; Hüwel S; Galla HJ
    Biochem Biophys Res Commun; 2011 Mar; 406(1):64-9. PubMed ID: 21295549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel flow based hollow-fiber blood-brain barrier in vitro model with immortalised cell line PBMEC/C1-2.
    Neuhaus W; Lauer R; Oelzant S; Fringeli UP; Ecker GF; Noe CR
    J Biotechnol; 2006 Aug; 125(1):127-41. PubMed ID: 16730091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human serum albumin nanoparticles modified with apolipoprotein A-I cross the blood-brain barrier and enter the rodent brain.
    Zensi A; Begley D; Pontikis C; Legros C; Mihoreanu L; Büchel C; Kreuter J
    J Drug Target; 2010 Dec; 18(10):842-8. PubMed ID: 20849354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
    Gao K; Jiang X
    Int J Pharm; 2006 Mar; 310(1-2):213-9. PubMed ID: 16426779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of the myosin light chain kinase prevents hypoxia-induced blood-brain barrier disruption.
    Kuhlmann CR; Tamaki R; Gamerdinger M; Lessmann V; Behl C; Kempski OS; Luhmann HJ
    J Neurochem; 2007 Jul; 102(2):501-7. PubMed ID: 17419808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on nerve growth factor liposomes on crossing blood-brain barrier in vitro and in vivo].
    Xie Y; Ye LY; Cui W; Xu K; Zhang XB; Lou JN; Hou XP
    Yao Xue Xue Bao; 2004 Nov; 39(11):944-8. PubMed ID: 15696939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of an in vitro blood-brain barrier model-cytotoxicity of mercury and aluminum.
    Toimela T; Mäenpää H; Mannerström M; Tähti H
    Toxicol Appl Pharmacol; 2004 Feb; 195(1):73-82. PubMed ID: 14962507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier.
    Mészáros M; Porkoláb G; Kiss L; Pilbat AM; Kóta Z; Kupihár Z; Kéri A; Galbács G; Siklós L; Tóth A; Fülöp L; Csete M; Sipos Á; Hülper P; Sipos P; Páli T; Rákhely G; Szabó-Révész P; Deli MA; Veszelka S
    Eur J Pharm Sci; 2018 Oct; 123():228-240. PubMed ID: 30031862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.